載入...
Soluble FLT1 Gene Therapy Alleviates Brain Arteriovenous Malformation Severity
BACKGROUND AND PURPOSE: Brain arteriovenous malformation (bAVM) is an important risk factor for intracranial hemorrhage. Current therapies are associated with high morbidities. Excessive vascular endothelial growth factor (VEGF) has been implicated in bAVM pathophysiology. Because soluble FLT1 binds...
Na minha lista:
| 發表在: | Stroke |
|---|---|
| Main Authors: | , , , , , , , , , , , , , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
2017
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5404983/ https://ncbi.nlm.nih.gov/pubmed/28325846 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1161/STROKEAHA.116.015713 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|